日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of atezolizumab combined with bevacizumab-based chemotherapy in advanced malignancies: a systematic review and meta-analysis of randomized trials

阿特珠单抗联合贝伐珠单抗化疗治疗晚期恶性肿瘤的疗效和安全性：随机试验的系统评价和荟萃分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-026-15799-5
Pakdaman, Kimia; Alizadeh-Nodehi, Amirhossein; Shirvani, Amin Esmaeilnia; Soleimani, Amir Morteza; Mohammadnia, Sara; Pakdaman, Kasra; Asghari, Mohammad Hossein; Ebrahimi, Pouyan
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

The role of mifepristone in managing myoma: a systematic review and meta-analysis of uterine parameters

米非司酮在子宫肌瘤治疗中的作用：子宫参数的系统评价和荟萃分析

期刊:BMC Womens Health
影响因子:2.7
doi:10.1186/s12905-026-04262-z
Ebrahimi, Pouyan; Pakdaman, Kimia; Esmaeilnia Shirvani, Amin; Advani, Seema; Farmahini Farahani, Maryam; Elyasi, Sima; Nourollahpour Shiadeh, Malihe
发表日期：2026
文献求助 收藏

Worldwide prevalence of haemorrhoids: a systematic review and meta-analysis

全球痔疮患病率：系统评价和荟萃分析

期刊:
影响因子:
doi:10.1080/07853890.2025.2606433
Esmaeilnia Shirvani, Amin; Pakdaman, Kimia; Maleki, Zahra; Soraneh, Soroush; Rezaei Chegini, Fatemeh; Pakdaman, Kasra; Vali, Mohebat; Nikbakht, Hossein-Ali; Shojaie, Layla; Ebrahimi, Pouyan
发表日期：2026
文献求助 收藏

Principal components of type 2 diabetes risk: an exploratory factor analysis in an Iranian cohort

2型糖尿病风险的主要组成部分：一项基于伊朗人群的探索性因素分析

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-025-21814-4
Geravandi, Sara; Emamgholipour, Sara; Pakdaman, Mohsen; Sari, Ali Akbari; Esmaeili, Alireza
糖尿病
代谢
发表日期：2025
文献求助 收藏

Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics

骨关节炎（OA）中间充质干细胞（MSCs）来源的细胞外囊泡（EVs）和微RNA（miRNAs）的详细作用及其在发病机制和潜在治疗中的作用

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2025.e42258
Pakdaman Kolour, Seyede Sara; Nematollahi, Saeide; Dehbozorgi, Masoud; Fattahi, Farnaz; Movahed, Fatemeh; Esfandiari, Neda; Kahrizi, Mohammad Saeed; Ghavamikia, Nima; Hajiagha, Bahareh Salmanian
发育与干细胞
细胞生物学
多发性硬化症
miRNA
干细胞
囊泡
关节炎
发表日期：2025
文献求助 收藏

Integration of Membrane-Based Pretreatment Methods with Pressure-Retarded Osmosis for Performance Enhancement: A Review

膜预处理方法与压力延迟渗透相结合以提高性能：综述

期刊:Materials
影响因子:3.2
doi:10.3390/ma18051020
Pakdaman, Sara; Nouri, Giti; Mulligan, Catherine N; Nasiri, Fuzhan
发表日期：2025
文献求助 收藏

Systematic review and meta analysis of the global incidence and clinicopathological characteristics of liver metastasis in patients with cervical cancer

对宫颈癌患者肝转移的全球发病率和临床病理特征进行系统评价和荟萃分析

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-04255-8
Pakdaman, Kimia; Esmaeilnia Shirvani, Amin; Pakdaman, Kasra; Karim, Bardia; Sahraian, Saba; Nikbakht, Hossein-Ali; Shojaie, Layla; Ebrahimi, Pouyan
宫颈癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Global incidence and risk factors of pregnancy-related stroke: a systematic review and meta-analysis of over 270 million women

全球妊娠相关卒中的发病率和危险因素：一项纳入超过2.7亿女性的系统评价和荟萃分析

期刊:BMC Pregnancy and Childbirth
影响因子:2.7
doi:10.1186/s12884-025-08404-3
Nourollahpour Shiadeh, Malihe; Pakdaman, Kimia; Esmaeilnia Shirvani, Amin; Hashemi, Zeinab; Ebrahimi, Pouyan
发表日期：2025
文献求助 收藏

Analysis of the Efficacy and Safety of Cabozantinib Monotherapy Versus Its Combination with Atezolizumab in Cancer Patients: A Systematic Review and Meta-Analysis

卡博替尼单药治疗与联合阿特珠单抗治疗癌症患者的疗效和安全性分析：系统评价和荟萃分析

期刊:Cancer Control
影响因子:2.6
doi:10.1177/10732748251371479
Pakdaman, Kimia; Nikbakht, Hossein-Ali; Esmaeilnia Shirvani, Amin; Sahraian, Saba; Shojaie, Layla; Ebrahimi, Pouyan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Brain Metastases in Cervical Cancer: A Global Systematic Review and Meta-Analysis of Incidence and Clinicopathological Features

宫颈癌脑转移：发病率和临床病理特征的全球系统评价和荟萃分析

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.70405
Pakdaman, Kimia; Alizadeh-Nodehi, Amirhossein; Lashkarbolouki, Amir-Hossein; Esmaeilnia Shirvani, Amin; Pakdaman, Kasra; Sahraian, Saba; Nikbakht, Hossein-Ali; Yeminfroz, Mosua; Ebrahimi, Pouyan
宫颈癌
肿瘤
肿瘤免疫
神经科学
发表日期：2025
文献求助 收藏